• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑热病皮肤利什曼病:一例报告

Para Kala-Azar Dermal Leishmaniasis: A Case Report.

作者信息

Moniruzzaman Md, Been Sayeed S K Jakaria, Rahim Md Abdur, Hassan Rashedul, Rahman Md Mujibur

机构信息

Internal Medicine, National Institute of Neuro Sciences & Hospital, Dhaka, BGD.

Internal Medicine, Shaheed Suhrawardy Medical College and Hospital, Dhaka, BGD.

出版信息

Cureus. 2023 Jan 12;15(1):e33701. doi: 10.7759/cureus.33701. eCollection 2023 Jan.

DOI:10.7759/cureus.33701
PMID:36788910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9922052/
Abstract

Rarely, post-kala-azar dermal leishmaniasis (PKDL) may coexist with visceral leishmaniasis (VL). The concomitant PKDL and VL are referred to as Para-kala-azar dermal Leishmaniasis. We report a case of Para kala-azar dermal leishmaniasis in a chronic Hepatitis-B virus-infected patient who presented with an abdominal lump and multiple maculopapular skin lesions and is resistant to sodium stibogluconate but successfully treated with liposomal Amphotericin-B.

摘要

罕见情况下,黑热病后皮肤利什曼病(PKDL)可能与内脏利什曼病(VL)同时存在。PKDL与VL并存被称为副黑热病皮肤利什曼病。我们报告一例副黑热病皮肤利什曼病病例,患者为慢性乙型肝炎病毒感染者,出现腹部肿块和多处斑丘疹性皮肤损害,对葡萄糖酸锑钠耐药,但用脂质体两性霉素B成功治愈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3e/9922052/df9c850230f7/cureus-0015-00000033701-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3e/9922052/1fddb37e5fe5/cureus-0015-00000033701-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3e/9922052/df9c850230f7/cureus-0015-00000033701-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3e/9922052/1fddb37e5fe5/cureus-0015-00000033701-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3e/9922052/df9c850230f7/cureus-0015-00000033701-i02.jpg

相似文献

1
Para Kala-Azar Dermal Leishmaniasis: A Case Report.黑热病皮肤利什曼病:一例报告
Cureus. 2023 Jan 12;15(1):e33701. doi: 10.7759/cureus.33701. eCollection 2023 Jan.
2
Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.对来自印度内脏利什曼病和皮肤利什曼原虫病患者的利什曼原虫菌株进行全基因组比较。
Acta Trop. 2021 Nov;223:106086. doi: 10.1016/j.actatropica.2021.106086. Epub 2021 Aug 10.
3
A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery.关于副内脏利什曼病皮肤利什曼病的病例报告:一个未解之谜。
BMC Infect Dis. 2023 Dec 18;23(1):885. doi: 10.1186/s12879-023-08918-1.
4
Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.在印度比哈尔邦,采用20毫克/千克脂质体两性霉素B(安必素)治疗原发性内脏利什曼病后出现的黑热病后皮肤利什曼病。
PLoS Negl Trop Dis. 2014 Jan 2;8(1):e2611. doi: 10.1371/journal.pntd.0002611. eCollection 2014.
5
Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.黑热病后皮肤利什曼病与麻风病:病例报告及文献综述
BMC Infect Dis. 2015 Nov 23;15:543. doi: 10.1186/s12879-015-1260-x.
6
Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.接受注射用抗利什曼原虫药物治疗的印度黑热病患者中的乙型和丙型肝炎病毒感染:一项基于社区的研究。
Int J Infect Dis. 2000;4(4):203-8. doi: 10.1016/s1201-9712(00)90110-3.
7
Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.印度比哈尔邦内脏利什曼病流行地区的黑热病后皮肤利什曼病。
Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12.
8
Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.巴西一名患者的皮肤利什曼病:病例报告
Rev Soc Bras Med Trop. 2018 Jan-Feb;51(1):105-107. doi: 10.1590/0037-8682-0487-2016.
9
IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.白蛉热和黑热病后皮肤利什曼病中白细胞介素-10和转化生长因子-β介导的易感性:两性霉素B在印度控制杜氏利什曼原虫感染中的意义
J Immunol. 2007 Oct 15;179(8):5592-603. doi: 10.4049/jimmunol.179.8.5592.
10
VL-HIV co-infection with Leishmania containing skin lesions resembling para-kala-azar dermal leishmaniasis.VL-HIV 合并感染利什曼原虫,皮肤损伤类似于皮肤型黑热病。
PLoS Negl Trop Dis. 2024 Aug 26;18(8):e0012438. doi: 10.1371/journal.pntd.0012438. eCollection 2024 Aug.

引用本文的文献

1
Unsupervised machine learning identifies biomarkers of disease progression in post-kala-azar dermal leishmaniasis in Sudan.无监督机器学习识别出苏丹黑热病后皮肤利什曼病疾病进展的生物标志物。
PLoS Negl Trop Dis. 2025 Mar 11;19(3):e0012924. doi: 10.1371/journal.pntd.0012924. eCollection 2025 Mar.
2
VL-HIV co-infection with Leishmania containing skin lesions resembling para-kala-azar dermal leishmaniasis.VL-HIV 合并感染利什曼原虫,皮肤损伤类似于皮肤型黑热病。
PLoS Negl Trop Dis. 2024 Aug 26;18(8):e0012438. doi: 10.1371/journal.pntd.0012438. eCollection 2024 Aug.
3
A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery.

本文引用的文献

1
Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.伴有内脏利什曼病的黑热病后皮肤利什曼病:一种罕见表现。
Int J Dermatol. 2005 Jun;44(6):494-6. doi: 10.1111/j.1365-4632.2004.02433.x.
2
Post-kala-azar dermal leishmaniasis.黑热病后皮肤利什曼病
Lancet Infect Dis. 2003 Feb;3(2):87-98. doi: 10.1016/s1473-3099(03)00517-6.
3
Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.苏丹的黑热病后皮肤利什曼病:临床表现与鉴别诊断
关于副内脏利什曼病皮肤利什曼病的病例报告:一个未解之谜。
BMC Infect Dis. 2023 Dec 18;23(1):885. doi: 10.1186/s12879-023-08918-1.
Br J Dermatol. 2000 Jul;143(1):136-43. doi: 10.1046/j.1365-2133.2000.03603.x.
4
Recurrence of kala-azar after PKDL: role of co-factors.
Trop Med Int Health. 1998 Jan;3(1):76-8. doi: 10.1046/j.1365-3156.1998.00176.x.
5
Post-kala-azar dermal Leishmaniasis in an HIV-patient.一名艾滋病患者的黑热病后皮肤利什曼病
Int J Dermatol. 1996 Apr;35(4):303-4. doi: 10.1111/j.1365-4362.1996.tb03014.x.
6
Distinguishing post-kala-azar dermal leishmaniasis from leprosy: experience in the Sudan.鉴别黑热病后皮肤利什曼病与麻风病:苏丹的经验
Lepr Rev. 1993 Mar;64(1):53-9. doi: 10.5935/0305-7518.19930007.
7
Kala azar with disseminated dermal leishmaniasis.伴有播散性皮肤利什曼病的黑热病
Am J Trop Med Hyg. 1989 Feb;40(2):150-3. doi: 10.4269/ajtmh.1989.40.150.
8
Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate.葡萄糖酸锑钠治疗黑热病后皮肤利什曼病
Br Med J (Clin Res Ed). 1987 Oct 10;295(6603):886-7. doi: 10.1136/bmj.295.6603.886-a.
9
Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment.苏丹的黑热病后皮肤利什曼病:临床特征、病理学及治疗
Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):245-8. doi: 10.1016/0035-9203(92)90294-m.